Jeffrey Bacha
2017
In 2017, Jeffrey Bacha earned a total compensation of $610.5K as President and Chief Executive Officer at DelMar Pharmaceuticals, a 239% increase compared to previous year.
Compensation breakdown
| Bonus | $56,250 |
|---|---|
| Option Awards | $249,257 |
| Salary | $305,000 |
| Total | $610,507 |
Bacha received $305K in salary, accounting for 50% of the total pay in 2017.
Bacha also received $56.3K in bonus and $249.3K in option awards.
Rankings
In 2017, Jeffrey Bacha's compensation ranked 11,123rd out of 14,666 executives tracked by ExecPay. In other words, Bacha earned more than 24.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,123 out of 14,666 | 24th |
Division Manufacturing | 4,345 out of 5,768 | 25th |
Major group Chemicals And Allied Products | 1,574 out of 2,074 | 24th |
Industry group Drugs | 1,294 out of 1,730 | 25th |
Industry Pharmaceutical Preparations | 1,009 out of 1,329 | 24th |
Source: SEC filing on March 9, 2018.
Bacha's colleagues
We found two more compensation records of executives who worked with Jeffrey Bacha at DelMar Pharmaceuticals in 2017.